Why was NIO formed?
2 billion people worldwide and nearly 100 million Americans suffer from a brain or nervous system illness. Brain-related illness generates more healthcare costs and lost income than any other therapeutic area: $2.0 trillion annually worldwide, $1.1 trillion annually in the US. This economic burden is accelerating as the population ages and expands, creating unprecedented demand for treatments that delay, prevent and cure chronic brain-related illness. Development of treatments for these disorders will help ensure a stable and efficient healthcare system in the face of an aging population. Despite the clear human need and significant global market opportunity, neurotechnology companies face unique investment requirements, research and development challenges, and regulatory milestones which can require more time and money to develop and deliver new treatments than in other life science and healthcare sectors. NIO was formed to provide commercial neuroscience organizations a collective vo
